Home > Insider Trading > Filing (0000902664-24-006775)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1755237	Cyclerion Therapeutics Inc.	CYCN	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1559706	Slate Path Capital Lp	717 5Th Avenue 16Th Fl. New York NY 10022		No	No	Yes	No
1820641	Gerald David Greenspan	C/O Slate Path Capital Lp 717 Fifth Avenue, 16Th Floor New York NY 10022		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Disposition	2024-11-21	357,880	$1.55	0	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote

Footnotes

The number of shares reported herein reflect the one-for-twenty reverse stock split effected by the Issuer on May 15, 2023.
The securities to which this filing relates were held by certain funds (the "Slate Path Funds"). Slate Path Capital LP (the "Investment Manager"), a Delaware limited partnership acts as the investment manager of the Slate Path Funds. Mr. David Greenspan serves as the managing member of Jades GP, LLC, a Delaware limited liability company and the general partner of the Investment Manager. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any.